# The Impact of Nutritional Management on Fat-Soluble Nutrient Status in Patients with Fatty Acid Oxidation Disorders: A Cross-Sectional Study

**Authors:** Maria Wasiewicz-Gajdzis, Małgorzata Jamka, Łukasz Kałużny, Natalia Wichłacz-Trojanowska, Anna Blask-Osipa, Monika Duś-Żuchowska, Joanna Jagłowska, Szymon Kurek, Anna Miśkiewicz-Chotnicka, Jarosław Walkowiak

PMC · DOI: 10.3390/metabo16020124 · Metabolites · 2026-02-11

## TL;DR

This study examines how dietary changes affect fat-soluble vitamin levels in patients with fatty acid oxidation disorders.

## Contribution

The study is the first to investigate the impact of fat-modified diets on fat-soluble vitamin status in FAOD patients.

## Key findings

- FAOD patients had higher vitamin A levels than controls.
- Fat-modified diets increased vitamin A and 25(OH)D but decreased vitamin E and β-carotene in FAOD patients.
- Vitamin 25(OH)D deficiency was more common in the standard-fat diet group.

## Abstract

Background: Fatty acid oxidation disorders (FAOD) are rare inborn errors of metabolism that impair mitochondrial β-oxidation and energy production. Management includes fasting avoidance for all FAOD types. Patients with long-chain FAOD are advised to restrict long-chain triglycerides (LCTs) to 10% of total energy intake and supplement medium-chain triglycerides (MCTs). The impact of such dietary modification on fat-soluble vitamin status has not yet been studied. Methods: In this cross-sectional study, serum concentrations of vitamins A, 25(OH)D, E, and β-carotene were measured in 36 FAOD patients and 36 healthy controls matched for age and sex. Vitamins A, E, and β-carotene were quantified using high-performance liquid chromatography and vitamin 25(OH)D through an immunoassay. FAOD patients were further divided into fat-modified (LCT-restricted) and standard-fat diet subgroups based on dietary management. Results: FAOD patients had significantly higher vitamin A concentrations than controls (p < 0.05), while there was no difference in vitamins 25(OH)D, E, and β-carotene. Within the FAOD cohort, the fat-modified group had higher levels of vitamins A and 25(OH)D but lower levels of vitamin E and β-carotene than the standard-fat group (all p < 0.05). Vitamin 25(OH)D deficiency (<20 ng/mL) was more frequent in the standard-fat group (p = 0.03). Conclusions: Fat-modified diets influence fat-soluble vitamin status in FAOD, emphasising the importance of ongoing monitoring and tailored supplementation. Future work should focus on optimising nutritional management, including modifications to formula composition, and on addressing the currently limited evidence on nutritional status and vitamin deficiencies in patients with FAOD.

## Full-text entities

- **Genes:** ACADVL (acyl-CoA dehydrogenase very long chain) [NCBI Gene 37] {aka ACAD6, LCACD, VLCAD}, HADHA (hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha) [NCBI Gene 3030] {aka ECHA, GBP, LCEH, LCHAD, MLCL AT, MTPA}
- **Diseases:** inborn errors of metabolism (MESH:D008661), FAOD (MESH:C536560), MCAD (MESH:C536038), LCTs (MESH:D000094024), Neuropathy (MESH:D009422), long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (MESH:C566945), CACT (MESH:C562812), rhabdomyolysis (MESH:D012206), carnitine palmitoyltransferase I deficiency (MESH:C535588), death (MESH:D003643), micronutrient deficiencies (MESH:D007153), infection (MESH:D007239), hypoglycemia (MESH:D007003), vitamin A deficiency (MESH:D014802), brain oedema (MESH:D001929), beta-carotene deficiency (MESH:D016537), retinopathy (MESH:D058437), vitamin D Deficiency (MESH:D014808), cardiomyopathy (MESH:D009202), febrile illness (MESH:D005334), Metabolic Diseases (MESH:D008659), SCAD (MESH:C537596), nutritional disturbances (MESH:D009748), hepatic insufficiency (MESH:D048550), injury to (MESH:D014947), mental disability (MESH:D001523), CUD (MESH:C536778), very long-chain acyl-CoA dehydrogenase deficiency (MESH:C536353)
- **Chemicals:** MCT (MESH:C000709826), alpha-tocopherol (MESH:D024502), beta-carotene (MESH:D019207), short-chain fatty acids (MESH:D005232), glucose (MESH:D005947), D (MESH:D003903), Lipistart (-), aluminum (MESH:D000535), carnitine (MESH:D002331), triheptanoin (MESH:C531010), tocopherol (MESH:D024505), oil (MESH:D009821), Fatty acid (MESH:D005227), acylcarnitine (MESH:C116917), carotenoid (MESH:D002338), E (MESH:D004540), Vitamin A (MESH:D014801), acetyl-CoA (MESH:D000105), fish liver oil (MESH:D005395), vitamin D (MESH:D014807), Fat (MESH:D005223), ammonia (MESH:D000641), Vitamin E (MESH:D014810), triglyceride (MESH:D014280), essential fatty acids (MESH:D005228), ketones (MESH:D007659)
- **Species:** Bos taurus (bovine, species) [taxon 9913], Daucus carota (carrot, species) [taxon 4039], Homo sapiens (human, species) [taxon 9606], Malus domestica (apple, species) [taxon 3750]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12943335/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12943335/full.md

## References

59 references — full list in the complete paper: https://tomesphere.com/paper/PMC12943335/full.md

---
Source: https://tomesphere.com/paper/PMC12943335